Adalta Ltd has released a press release.
Trading Halt
Filed with ASX ·
On 6ix: 6ix.com/news/trading-halt-1187
6ix hasn’t read this filing yet.
Earlier from AdAlta
- SYNBV invest up to $2m in East to West subsidiary
- R&D Tax Incentive advance received
- Investor Presentation
- East to West cell therapy strategy update
- AD-214 clinical advisory board
Later from AdAlta
- Renounceable Rights Issue to Raise up to $1.3 million
- Prospectus
- Notice of change of exercise price of options
- Rights Issue raises $1.1million
- Renounceable Rights Issue shortfall placed
Follow AdAlta into a list and get an email when it puts out news.
Follow AdAlta